Low-dose oral cocaine in humans: Acquisition of discrimination and time-course of effects

Behavioural Pharmacology

Volumn 10, Issue 5, 1999, Pages 531-542

  Epstein, D H ^a   Silverman, K ^b   Henningfield, J E ^b   Preston, K L ^a,b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; Drug abuse; Drug discrimination; Humans; Oral administration

Indexed keywords

COCAINE;

ADULT; ALERTNESS; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG ABUSE; DRUG DISCRIMINATION; DRUG EFFECT; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; MOTOR PERFORMANCE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION;

EID: 0032822065     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199909000-00011     Document Type: Article

References (34)

1. Bell SM, Macenski, MJ, Silverman, PB, Meisch RA (1993). Water deprivation-induced oral self-administration of cocaine in the Lewis rat: evidence for locomotor effects but not reinforcement. Pharmacol Biochem Behav 45:749-754.
2. Bowman EM, Aigner TG, Richmond BJ (1996). Neural signals in the monkey ventral striatum related to motivation for juice and cocaine rewards. J Neurophysiol 75:1061-1073.
3. Falk JL, Ma F, Chyan LE (1990). Chronic oral cocaine self-administration: Pharmacokinetics and effects on spontaneous and discriminative motor functions. J Pharmacol Exp Ther 257:457-465.
4. Fischman MW, Schuster CR, Rcsnekov L et al. (1976). Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch Gen Psychiatry 33:983-989.
5. Follin RW, Fischman MW (1991). Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. J Pharmacol Exp Ther 257:247-261.
6. Foltin RW, Fischman MW, Pippen PA, Kelly TH (1993). Behavioral effects of cocaine alone and in combination with ethanol or marijuana in humans. Drug Alcohol Depend 32:93-106.
7. George FR, Goldberg SR (1988). Genetic differences in responses to cocaine. In: Mechanisms of Cocaine Abuse and Toxicity. Clouet D, Asghar K, Brown R (editors). NIDA Res Monogr 88:239-249.
8. Haertzen CA (1974). An overview of Addiction Research Center Inventory scales (ARCI); An Appendix and Manual of Scales. Washington, DC: US Government Printing Office, pp. 74-92.
9. Hanna JM (1970). The effects of coca chewing on exercise in the Quechua of Peru. Human Biol 42:1-11.
10. Higgins ST, Bickel WK, Hughes JR, Lynn M, Capeless MA, Fenwick JW (1990). Effects of intranasal cocaine on human learning, performance and physiology. Psychopharmacology 102:451-458.
11. Keselman HJ, Keselman JC, Shaffer JP (1991). Multiple pairwise comparisons of repeated measures means under violation of multisample sphericity. Psychol Bull 110:162-170.
12. Lau CE, Abdulrazaq I, Ma F, Falk JL (1990). Acute effects of on spontaneous and discriminative motor functions: Relation to route of administration and pharmacokinetics. J Phamacol Exp Ther 257:444-456.
13. Licata A, Taylor S, Berman M, Cranston J (1993). Effects of cocaine on human aggression. Pharmacol Biochem Behav 45:549-552.
14. Lukas SE, Sholar M, Lundahl LH et al. (1996). Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacology 125:346-354.
15. Meisch RA, George FR, Lemaire GA (1990). Orally delivered cocaine as a reinforcer for rhesus monkeys. Pharmacol Biochem Behav 35:245-249.
16. Mumford GK, Evans SM, Kaminski BJ et al. (1994). Discriminative stimulus and subjective effects of theobromine and caffeine in humans. Psychopharmacology 115:1-8.
17. Musto DF (1992). Cocaine's history, especially the American experience. In: Cocaine: Scientific and Social Dimensions. Ciba Foundation Symposium 166. Chichester: Wiley, pp. 7-19.
18. Oliveto AH, Rosen MI, Woods SW, Kosten TR (1995). Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans. J Pharmacol Exp Ther 272:231-241.
19. Oliveto AH, McCance-Katz E, Singha A, Hameedi F, Kosten TR (1998). Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure. Behav Pharmacol 9:207-217.
20. Ortiz VZ (1952). The problem of the chewing of the coca leaf in Peru. Bull Narcotics 4:26-33.
21. Paly D, Jatlow P, Van Dyke C, Jeri FR, Byck R (1982). Plasma cocaine concentrations during cocaine paste smoking. Life Sci 30:731-738.
22. Pendergrast M (1993). For God, Country, and Coca-Cola: The Unauthorized History of the Great American Soft Drink and the Company That Makes It. New York: Scribners.
23. Post RM, Gillin JC, Wyatt RJ, Goodwin FK (1974a). The effects of orally administered cocaine on sleep of depressed patients, Psychopharmacologia 37:59-66.
24. Post RM, Kotin J, Goodwin FK (1974b). The effects of cocaine on depressed patients. Am J Psychiatry 131:511-517.
25. Preston KL, Bigelow GE (1991). Subjective and discriminative effects of drugs, Behav Pharmacol 2:293-313.
26. Ritchie JM, Cohen PJ (1975). Cocaine, procaine, and other synthetic local anesthetics. In: The Pharmacological Basis of Therapeutics (5th edn). Goodman LS, Gilman A (editors). New York: Macmillan, pp. 379-403..
27. Siegel RK, ElSohly MA, Plowman T, Rury PM, Jones RT (1986). Cocaine in herbal tea. J Am Med Assoc 255:40.
28. Silverman K, Mumford GK, Griffiths RR (1994). A procedure for studying the within session onset of human drug discrimination. J Exp Anal Behav 61:181-189.
29. Stillman R, Jones RT, Moore D, Walker J, Welm S (1993). Improved performance 4 hours after cocaine. Psychopharmacology 110:415-420.
30. Van Dyke C, Byck R (1983). Cocaine use in man. Adv Substance Abuse 3:1-24.
31. Van Dyke C, Jatlow P, Ungerer J, Barash PG, Byck R (1978). Oral cocaine: plasma concentrations and central effects. Science 200:211-213.
32. Vereby K, Gold MS (1988). From coca leaves to crack: the effects of dose and route of administration in abuse liability. PsychiatrAnn 18:513-520.
33. Weil AT (1978). Coca leaf as a therapeutic agent. Am J Drug Alcohol Abuse 5:75-86.
34. Wilkinson P, Van Dyke C, Jatlow P, Barash P, Byck R (1980). Intranasal and oral cocaine kinetics. Clin Pharmacol Ther 27:386-394.